Perbak Capital Partners LLP Idexx Laboratories Inc Transaction History
Perbak Capital Partners LLP
- $568 Billion
- Q3 2025
A detailed history of Perbak Capital Partners LLP transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Perbak Capital Partners LLP holds 1,228 shares of IDXX stock, worth $847,234. This represents 0.14% of its overall portfolio holdings.
Number of Shares
1,228
Previous 6,365
80.71%
Holding current value
$847,234
Previous $3.41 Billion
77.02%
% of portfolio
0.14%
Previous 0.77%
Shares
4 transactions
Others Institutions Holding IDXX
# of Institutions
1,455Shares Held
73.6MCall Options Held
252KPut Options Held
200K-
Vanguard Group Inc Valley Forge, PA9.96MShares$6.87 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$6.63 Billion0.11% of portfolio
-
State Street Corp Boston, MA3.52MShares$2.43 Billion0.08% of portfolio
-
Terry Smith Fundsmith LLP | London, X02.61MShares$1.8 Billion8.47% of portfolio
-
Geode Capital Management, LLC Boston, MA2.5MShares$1.72 Billion0.11% of portfolio
About IDEXX LABORATORIES INC
- Ticker IDXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 83,253,696
- Market Cap $57.4B
- Description
- IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...